These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20504289)

  • 1. A novel serum-free medium for the expansion of human mesenchymal stem cells.
    Chase LG; Lakshmipathy U; Solchaga LA; Rao MS; Vemuri MC
    Stem Cell Res Ther; 2010 Apr; 1(1):8. PubMed ID: 20504289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
    Chase LG; Yang S; Zachar V; Yang Z; Lakshmipathy U; Bradford J; Boucher SE; Vemuri MC
    Stem Cells Transl Med; 2012 Oct; 1(10):750-8. PubMed ID: 23197667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.
    Fekete N; Gadelorge M; Fürst D; Maurer C; Dausend J; Fleury-Cappellesso S; Mailänder V; Lotfi R; Ignatius A; Sensebé L; Bourin P; Schrezenmeier H; Rojewski MT
    Cytotherapy; 2012 May; 14(5):540-54. PubMed ID: 22296115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous Platelet Lysate Does Not Enhance Chondrogenic Differentiation of Equine Bone Marrow-Derived Mesenchymal Stromal Cells Despite Increased TGF-β1 Concentration.
    Chapman HS; Gale AL; Dodson ME; Linardi RL; Ortved KF
    Stem Cells Dev; 2020 Feb; 29(3):144-155. PubMed ID: 31802705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of expansion media and fibronectin coating on growth and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells.
    Basoli V; Della Bella E; Kubosch EJ; Alini M; Stoddart MJ
    Sci Rep; 2021 Jun; 11(1):13089. PubMed ID: 34158528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of medium supplements on proliferation, differentiation potential, and in vitro expansion of mesenchymal stem cells.
    Gharibi B; Hughes FJ
    Stem Cells Transl Med; 2012 Nov; 1(11):771-82. PubMed ID: 23197689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic chromatin accessibility and transcriptome changes following PDGF-BB treatment of bone-marrow derived mesenchymal stem cells.
    Liu S; Chu X; Reiter JL; Yu X; Fang F; McGuire P; Gao H; Liu Y; Wan J; Wang Y
    BMC Genomics; 2024 Oct; 25(1):962. PubMed ID: 39407135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis.
    Hegner B; Schaub T; Catar R; Kusch A; Wagner P; Essin K; Lange C; Riemekasten G; Dragun D
    PLoS One; 2016; 11(4):e0153101. PubMed ID: 27054717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells.
    Antoon R; Yeger H; Loai Y; Islam S; Farhat WA
    J Biomed Mater Res A; 2012 Jan; 100(1):72-83. PubMed ID: 21972045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
    Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
    Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells.
    Fitzgerald JC; Shaw G; Murphy JM; Barry F
    Stem Cell Res Ther; 2023 Dec; 14(1):363. PubMed ID: 38087388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
    Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR
    J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells.
    Devireddy LR; Myers M; Screven R; Liu Z; Boxer L
    PLoS One; 2019; 14(2):e0210250. PubMed ID: 30811421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Development of Umbilical Cord-Derived Mesenchymal Stem Cells During Long-Term Maintenance in Fetal Bovine Serum-Supplemented Medium and Xeno- and Serum-Free Culture Medium.
    Le HM; Nguyen LT; Hoang DH; Bach TQ; Nguyen HTN; Mai HT; Trinh DP; Nguyen TD; Nguyen LT; Than UTT
    Cell Reprogram; 2021 Dec; 23(6):359-369. PubMed ID: 34748399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture.
    Schubert S; Brehm W; Hillmann A; Burk J
    Cytometry A; 2018 Jan; 93(1):60-72. PubMed ID: 28926198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of xenogenic-free expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells.
    Brun J; Abruzzese T; Rolauffs B; Aicher WK; Hart ML
    Cytotherapy; 2016 Mar; 18(3):344-59. PubMed ID: 26857228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells.
    Czapla J; Matuszczak S; Kulik K; Wiśniewska E; Pilny E; Jarosz-Biej M; Smolarczyk R; Sirek T; Zembala MO; Zembala M; Szala S; Cichoń T
    Stem Cell Res Ther; 2019 Aug; 10(1):235. PubMed ID: 31383013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.
    Altrock E; Sens-Albert C; Hofmann F; Riabov V; Schmitt N; Xu Q; Jann JC; Rapp F; Steiner L; Streuer A; Nowak V; Obländer J; Weimer N; Palme I; Göl M; Darwich A; Wuchter P; Metzgeroth G; Jawhar M; Hofmann WK; Nowak D
    Stem Cell Res Ther; 2023 Jun; 14(1):156. PubMed ID: 37287056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
    Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H
    Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.